BriaCell Therapeutics Corp.
BCTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001610820
No open-market purchases or sales by BriaCell Therapeutics Corp. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $1.58M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in BriaCell Therapeutics Corp. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- 0 vs. Q2 2023
- Shares held
- 2.71M
- −67.5K (−2.4%) vs. Q2 2023
- Total value
- $17.0M
- −$860.9K (−4.8%) vs. Q2 2023
- New holders
- 3
- 7 more added
- Sold out
- 3
- 5 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $1.58M |
| Q1 2026 | 16 | $1.62M |
| Q4 2025 | 13 | $69.2K |
| Q3 2025 | 13 | $136.5K |
| Q2 2025 | 16 | $181.1K |
| Q1 2025 | 14 | $94.1K |
| Q4 2024 | 26 | $379.1K |
| Q3 2024 | 22 | $538.1K |
| Q2 2024 | 20 | $452.0K |
| Q1 2024 | 20 | $6.38M |
| Q4 2023 | 26 | $14.6M |
| Q3 2023 | 21 | $17.0M |
| Q2 2023 | 21 | $17.9M |
| Q1 2023 | 21 | $19.4M |
| Q4 2022 | 21 | $12.3M |
| Q3 2022 | 22 | $14.3M |
| Q2 2022 | 22 | $17.0M |
| Q1 2022 | 18 | $33.5M |
| Q4 2021 | 20 | $10.9M |
| Q3 2021 | 21 | $4.77M |
| Q2 2021 | 24 | $20.3M |
| Q1 2021 | 10 | $1.45M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding BriaCell Therapeutics Corp.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lynwood Capital Management Inc. | 1,582,450 | $9.89M | 26.01% | −1,428−0.1% | Reduced |
| Wasatch Advisors Inc | 513,761 | $3.21M | 0.02% | −98,327−16.1% | Reduced |
| Redmond Asset Management, LLC | 137,839 | $861.5K | 0.31% | +150+0.1% | Added |
| Natixis | 95,581 | $597.4K | 0.00% | +5,331+5.9% | Added |
| Morgan Stanley | 95,015 | $593.8K | 0.00% | +19,787+26.3% | Added |
| K.J. Harrison & Partners Inc | 66,090 | $411.1K | 0.09% | +31,450+90.8% | Added |
| Susquehanna International Group, LLP | 52,067 | $325.4K | 0.00% | +33,202+176.0% | Added |
| Bank of Montreal | 37,629 | $265.4K | 0.00% | +3,000+8.7% | Added |
| Summit Trail Advisors, LLC | 35,000 | $218.8K | 0.01% | 00.0% | Unchanged |
| K2 Principal Fund, L.P. | 24,969 | $156.1K | 0.05% | +24,969 | New |
| Bank of America Corp | 17,662 | $110.4K | 0.00% | +16,535+1,467.2% | Added |
| HighTower Advisors, LLC | 15,887 | $99.0K | 0.00% | −200−1.2% | Reduced |
| TD Waterhouse Canada Inc. | 12,050 | $90.6K | 0.00% | 00.0% | Unchanged |
| Concord Wealth Partners | 10,775 | $67.3K | 0.01% | −4,500−29.5% | Reduced |
| Renaissance Technologies LLC | 10,200 | $64.0K | 0.00% | +10,200 | New |
| Royal Bank of Canada | 3,600 | $23.0K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 2,500 | $14.9K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 528 | $3.30K | 0.00% | −861−62.0% | Reduced |
| Toronto Dominion Bank | 33 | $206 | 0.00% | +33 | New |
| Advisor Group Holdings, Inc. | 32 | $200 | 0.00% | 00.0% | Unchanged |
| Rosenberg Matthew Hamilton | 12 | $75 | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −63,650−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −39,521−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −3,688−100.0% | Sold out |